Repository logo
  • English
  • Deutsch
  • Español
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?

  • English
  • Deutsch
  • Español
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • Research Outputs
  • Fundings & Projects
  • Researchers
  • Statistics
  1. Home
  2. Current Research Information System UV
  3. Publicaciones
  4. In Vitro Antifungal Activity And Toxicity Of Dihydrocarvone-Hybrid Derivatives Against Monilinia Fructicola
 
  • Details
Options

In Vitro Antifungal Activity And Toxicity Of Dihydrocarvone-Hybrid Derivatives Against Monilinia Fructicola

Journal
Antibiotics
Date Issued
2021-07-06
Author(s)
Katy Díaz
Enrique Werner
Ximena Besoain
Susana Flores
Viviana Donoso
Bastian Said
Nelson Caro
Ernesto Vega
Alejandro Madrid
Montenegro, Iván  
Facultad de Medicina  
DOI
10.3390/antibiotics10070818
WoS ID
WOS:000678169900001
Abstract
The aim of this study was to synthesize a series of novel and known dihydrocarvone-hybrid derivatives (2–9) and to evaluate mycelial growth activity of hybrid molecules against two strains of Monilinia fructicola, as well as their toxicity. Dihydrocarvone-hybrid derivatives have been synthesized under sonication conditions and characterized by FTIR, NMR, and HRMS. Antifungal efficacy against both strains of M. fructicola was determined by half maximal effective concentration (EC50) and toxicity using the brine shrimp lethality test (BSLT). Among the synthesized compounds, 7 and 8 showed the best activity against both strains of M. fructicola with EC50 values of 148.1 and 145.9 µg/mL for strain 1 and 18.1 and 15.7 µg/mL for strain 2, respectively, compared to BC 1000® (commercial organic fungicide) but lower than Mystic® 520 SC. However, these compounds showed low toxicity values, 910 and 890 µg/mL, respectively, compared to Mystic® 520 SC, which was highly toxic. Based on the results, these hybrid compounds could be considered for the development of more active, less toxic, and environmentally friendly antifungal agents against phytopathogenic fungi.
Subjects

Biochemistry

Infectious Diseases

Microbiology

Pharmacology And Phar...

Pharmacology

Pharmacology, Toxicol...

OCDE Subjects

Medical And Health Sc...

Quartile (Date Issued)
Q1
License
acceso abierto
Open Science Path
https://creativecommons.org/licenses/by/4.0/

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback

Hosting & Support by

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science